Investor's Calendar
Last News

ROVI reached 201.9 million euros of revenue in the first post-pandemic quarter
3 min
10 May, 2023

The objective of the new three-monthly formulation is to reach bioequivalence in the plasma levels of...
6 min
25 Apr, 2023

The objective is to help improve society’s mental health and take advantage of the opportunities the new...
3 min
12 Apr, 2023
Public statements sent to CNMV
ESG
Discover what ROVI is doing to become a more sustainable company
CORPORATE GOVERNANCE
Find out more about ROVI’s main governing bodies
Information for investors

Marta Campos
Head of Investor Relations

Antonio Marquina
Investor Relations
